Sowell Financial Services’s VanEck Pharmaceutical ETF PPH Stock Holding History

Sowell Financial Services’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-100	Closed	-$7K	–	2137
2021 Q1	$7K	Hold	100	–	–	﹤0.01%	2475
2020 Q4	$7K	Hold	100	–	–	﹤0.01%	2172
2020 Q3	$6K	Hold	100	–	–	﹤0.01%	1958
2020 Q2	$6K	Hold	100	–	–	﹤0.01%	1852
2020 Q1	$5K	Hold	100	–	–	﹤0.01%	1828
2019 Q4	$6K	Hold	100	–	–	﹤0.01%	1853
2019 Q3	$6K	Buy	+100	New	+$5.73K	﹤0.01%	1708

Other funds holding PPH

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

22CM

20/20 Capital Management Costa Mesa, California $386M AUM 30.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Sowell Financial Services's PPH Position: Q2 2021 in Review

Sowell Financial Services sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2021, closing a stake of 100 shares — an estimated $7K sold.

Sowell Financial Services first reported a position in PPH in Q3 2019 and held it in 7 quarters. The position peaked at $7K in Q1 2021. 54 funds tracked by Wall St. Rank hold PPH as of Q2 2021.

Sowell Financial Services reported no remaining VanEck Pharmaceutical ETF position as of Q2 2021 after selling out during the quarter.
Sowell Financial Services sold 100 VanEck Pharmaceutical ETF shares in Q2 2021, an estimated $7K.
Sowell Financial Services first reported a position in VanEck Pharmaceutical ETF in Q3 2019 and held it in 7 quarters.
Sowell Financial Services's VanEck Pharmaceutical ETF position peaked at $7K in Q1 2021.
54 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.